(Q40549992)

English

Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use.

scientific article published on 20 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use. (English)

1 reference

Europe PubMed Central

21 September 2017

Anita Hokken-Koelega

1

object named as

Anita Hokken-Koelega

1 reference

Europe PubMed Central

21 September 2017

author name string

Alexandra Keller

2

1 reference

Europe PubMed Central

21 September 2017

Viatcheslav Rakov

3

1 reference

Europe PubMed Central

21 September 2017

Stefan Kipper

4

1 reference

Europe PubMed Central

21 September 2017

Jovanna Dahlgren

5

1 reference

Europe PubMed Central

21 September 2017

publication date

20 September 2011

1 reference

Europe PubMed Central

21 September 2017

Isrn endocrinology

1 reference

Europe PubMed Central

21 September 2017

2011

1 reference

Europe PubMed Central

21 September 2017

803948

1 reference

Europe PubMed Central

21 September 2017

copyright license

Creative Commons Attribution 3.0 Unported

20 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Evaluation of the Use of PenNeedle(®) 32G Taper in Children being Treated with Growth Hormone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

22 September 2017

Understanding and meeting the needs of those using growth hormone injection devices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

22 September 2017

Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

22 September 2017

Optimizing gh therapy in adults and children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

22 September 2017

A history of growth hormone injection devices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

22 September 2017

Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

22 September 2017

Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

25 September 2017

Evaluation of a pen injector system for growth hormone treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

17 June 2018

Monitoring of concordance in growth hormone therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

20 August 2018

Facilitating and understanding the family's choice of injection device for growth hormone therapy by using conjoint analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

20 August 2018

Patient outcomes in the GHMonitor: the effect of delivery device on compliance and growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

20 August 2018

Factors determining patient choice of device for GH therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

20 August 2018

Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

20 August 2018

Compliance with growth hormone treatment--are they getting it?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262649

20 August 2018

Multicentre survey on compliance with growth hormone therapy: what can be improved?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multiple indications for growth hormone treatment of pediatric patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Automatic needle insertion diminishes pain during growth hormone injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.5402/2011/803948

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40549992&oldid=2063691984"